Comments

INMB

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$8.17

NaN%

After Hours: 4:00 PM EDT

15 minutes delayed

Q2 2024 Earnings were released on Thu Aug 1st, after the market close

The most recent conference call was at 16:30 PM, 2 days ago Click to view past webcast

(INMB) Forecast

News Earnings Guidance Dividends Analyst Ratings Insider Trades Short Interest

(INMB) Stock Quotes, Forecast and News Summary

INMB stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	- / -
Day Range	- - -
52 Wk Range	- - -
Market Cap	-
P/E Ratio	-
Dividend Yield	-
Exchange
RSI	46
Short Interest	17.78%
Days to Cover	19.43

Recent News

Why Elevai Labs Stock Is Trading Higher

Elevai Labs, Inc. (NASDAQ:ELAB) shares are trading higher Tuesday after the company announced it signed an exclusive, worldwide manufacturing and processing technology licensing agreement with INmune Bio, Inc. (NASDAQ:INMB).

Erica Kollmann

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About

Sector

Healthcare

Industry

N/A

INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new im...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.